<< All Companies

Dendreon Corporation

About Dendreon Corporation

Dendreon Corporation (NASDAQ: DNDN) is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization, and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering, and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types. Dendreonā€™s first product, PROVENGEĀ® (sipuleucel-T), was approved by the U.S. Food and Drug Administration (FDA) in April 2010 and by the European Medicines Agency in 2013. Dendreon is exploring the application of additional ACI product candidates and small molecules for the potential treatment of a variety of cancers. The Company is headquartered in Seattle, Washington and has manufacturing facilities in Georgia and California.

Dendreon Corporation Reviews
Recommend to a friend
Approve of management

Dendreon Corporation LOCATIONS


Dendreon Corporation Headquarters

3005 First Avenue ,

Seattle, WA

206-256-4545 phone
206-256-0571 fax
Seattle Salaries
Washington Salaries

Your Dendreon Corporation Experience

Dendreon Corporation


Do you currently work at Dendreon Corporation? Have you worked there in the past? Please rate your expierence and share your thoughts!

More Jobs at Dendreon Corporation